HealthcareServices

Monocyte Activation Test Industry Poised for Rapid Growth, Forecast to Touch $1.07 Billion by 2030 at 14.6% CAGR

February 26, 2026March 4, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the monocyte activation test market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Monocyte Activation Test Market in 2030?

The monocyte activation test market has seen substantial expansion in recent years. Its valuation is set to climb from $0.54 billion in 2025 to $0.63 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.9%. The historical growth trajectory is largely a result of increasing biologics development endeavors, stricter regulatory inspections on pyrogen safety, the shift away from animal-based testing procedures, an expansion in pharmaceutical quality control assessments, and growing investments in in vitro testing solutions.

The monocyte activation test market is anticipated to experience substantial growth over the coming years. It is projected to reach $1.08 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.6%. This expected expansion during the forecast period can be attributed to the rising adoption of advanced biologics and vaccines, an increasing demand for high-throughput safety testing, the proliferation of automated laboratory workflows, growing regulatory endorsement for animal-free testing, and the enhanced integration of digital lab platforms. Noteworthy trends identified for the forecast period include the increasing uptake of animal-free pyrogen testing, a rising utilization of automated MAT assay systems, the broadening integration of data management software, the expansion of GMP-compliant testing solutions, and an amplified focus on the regulatory acceptance of MAT.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24610&type=smp

What Drivers Are Influencing Production Trends In The Monocyte Activation Test Market?

The expanding occurrence of autoimmune disorders is anticipated to fuel the progression of the monocyte activation test market. Autoimmune disorders involve the body’s immune system erroneously attacking its own healthy cells, tissues, or organs instead of defending against infections and foreign materials. The heightened prevalence of these disorders largely stems from increased exposure to pollutants, which can upset immune regulation and provoke irregular responses. The monocyte activation test (MAT) facilitates the detection of autoimmune disorders by offering a dependable approach for evaluating immune system activation. It assists in recognizing abnormal immune responses, which is vital for diagnosing conditions like lupus and rheumatoid arthritis, thereby enhancing their early detection and management. For example, Arthritis Australia, an Australia-based non-profit organization, reported in February 2024 that an estimated 562,378 Australians are projected to have RA in 2025, constituting 14% of all arthritis cases for that year. This figure is expected to climb by 33% to 748,721 people by 2040, marking an increase of 186,343 Australians with RA compared to 2025. Consequently, the rising frequency of autoimmune disorders is a key factor driving the expansion of the monocyte activation test market. The growing occurrence of healthcare-associated infections (HAIs) is projected to advance the monocyte activation test market. HAIs are infections acquired by patients during medical treatment within a healthcare setting. The increase in these infections is primarily fueled by the greater use of invasive medical devices, which can introduce pathogens into the body and elevate the risk of infection. The monocyte activation test assists in tackling HAIs by facilitating the early detection of pyrogens, thereby allowing for the development of safer medical devices and injectable products that diminish the likelihood of infection-related issues. For instance, in January 2025, the National Library of Medicine, a US-based organization known for its extensive biomedical literature and data access, stated that among 13,654 patients across 218 hospitals, 357 (2.6%) were found to have 392 HAIs. Patients with HAIs, when compared to those without, were more commonly found in larger hospitals and critical care units. As a result, the rising incidence of healthcare-associated infections is a significant force behind the expansion of the monocyte activation test market.

Which Segment Groups Are Influencing The Monocyte Activation Test Market?

The monocyte activation test market covered in this report is segmented –

1) By Product Type: Reagents, Test Kits, Assay Systems, Software Solutions

2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Flow Cytometry, Polymerase Chain Reaction (PCR), Luminex Technologies

3) By Distribution Channel: Direct Sales, Distributors Or Third-party Partners, Online Retailers, Institutional Sales

4) By Application: Drug Development, Vaccine Development, Medical Device Testing, Other Applications

5) By End-User: Pharmaceutical Companies, Biotechnology Companies, Research Institutions, Hospitals And Laboratories

Subsegments:

1) By Reagents: Endotoxin Standards, Cytokine Detection Reagents, Cell Culture Media, Limulus Amebocyte Lysate (LAL) Reagents, Blocking Agents And Buffers

2) By Test Kits: Quantitative Monocyte Activation Test Kits, Qualitative Monocyte Activation Test Kits, Good Manufacturing Practice (GMP)-Compliant Test Kits, Endotoxin-Specific Test Kits, Pyrogen Detection Kits

3) By Assay Systems: Benchtop Monocyte Activation Analyzers, Automated High-Throughput Systems, Microplate Readers, Cell Imaging Systems, Flow Cytometry-Based Systems

4) By Software Solutions: Data Analysis Software, Laboratory Information Management Systems (LIMS) Integration Tools, Compliance And Audit Trail Software, Remote Monitoring And Control Software, Real-Time Result Interpretation Tools

What Trends Are Driving The Growth Trajectory Of The Monocyte Activation Test Market?

Companies at the forefront of the monocyte activation test market are dedicated to creating technologically advanced monocyte activation test (MAT) products, including pyrogen and endotoxin tests. This focus is intended to increase test sensitivity and enhance the detection of immune responses. Pyrogen and endotoxin tests are utilized to identify substances that induce fever, especially endotoxins derived from gram-negative bacteria. For example, in June 2024, FUJIFILM Wako Pure Chemicals Corporation, a Japan-based chemical manufacturer, released the LumiMAT Pyrogen Detection Kit, a next-generation monocyte activation test for in vitro pyrogen screening, and PYROSTAR Neo+, a recombinant protein reagent specifically for detecting bacterial endotoxins. These introductions significantly improve the accuracy, efficiency, and safety of pyrogen testing within the pharmaceutical and biotechnology sectors.

Who Are The Primary Competitors In The Global Monocyte Activation Test Market?

Major companies operating in the monocyte activation test market are Merck KGaA, Becton Dickinson and Company, Eurofins Scientific, Lonza Group, Charles River Laboratories, Nelson Laboratories LLC, Solvias AG, Labor LS SE and Co. KG, BMG Labtech, Cellular Technology Limited, Creative Biolabs, FUJIFILM Wako Chemicals, Microcoat Biotechnologie GmbH, MAT BioTech B.V., Sanquin Diagnostiek B.V., PyroDex LLC, MAT Research B.V., Minerva Biolabs GmbH, Wickham Micro Limited, Rapid Test Methods Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/monocyte-activation-test-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Monocyte Activation Test Market?

North America was the largest region in the monocyte activation test market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the monocyte activation test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Monocyte Activation Test Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24610&type=smp

Browse Through More Reports Similar to the Global Monocyte Activation Test Market 2026, By The Business Research Company

Neurogenetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurogenetic-testing-global-market-report

C Reactive Protein Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report

Genotyping Assay Market Report 2026

https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795